Loading...
OTC Markets
Totals
Securities
12,304
Dollar Vol
$2.5B
Share Vol
3.8B
Trades
319,611

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

AXIM
Axim Biotechnologies, Inc.

Common Stock

0.0069

0.0009

15.00%

0.0058 / 0.0069 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 06/13/2025
Delayed (15 Min) Trade Data: 12:00am 06/13/2025
Axim Biotechnologies, Inc. Company Logo

6048 Cornerstone Ct W

Suite E1

San Diego, CA 92121

Business Description
Axim Biotechnologies, Inc. is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Axim's core competencies include development of rapid lateral flow immunoassays, reagents and monoclonal antibody development for such assays.
Financial Reporting
Reporting Status
Alternative Reporting Standard
Audited Financials
Audited
CIK
0001514946
Fiscal Year End
12/31
Company Officers & Contacts
Catalina Valencia
President

Robert T. Malasek
CFO

Phillip E Koehnke APC
Corporate Counsel

Board of Directors
Robert L Cunningham
Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Peter O'Rourke

Blake N. Schroeder

Timothy R Scott
Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Catalina Valencia

Other Company Insiders
Public Company
Medical Marijuana, Inc.
John Huemoeller
Juniper & Ivy Corp.
Sergie Svarovsky
Glycodots, LLC
Catalina Valencia
Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Securities Counsel
Greenberg Traurig LLP

1201 K Street

Suite 1100

Sacramento, CA 95814

Securities Counsel
Phillip E. Koehnke, APC

PO Box 2025

Carlsbad, CA 92018

Profile Data
SIC - Industry Classification
2834 - Pharmaceutical preparations
Incorporation Information
NV, US, 2010
Employees
8 as of 01/08/2025
Shell
No
Products and Services

Our current product portfolio falls under the Eye Health sector and consist of the two FDA cleared 510(k) tests we acquired for dry eye disease (“DED”) and allergic conjunctivitis, both testing tears for these diseases . We have also internally developed an immunoassay for a potential third product which would measure MMP-9 in tears. MMP-9 is a biomarker for ocular surface inflammation and is an additional diagnostic tool for DED and other eye diseases.

Company Facilities

Our principal executive office and laboratory is located at 6048 Cornerstone Ct W Suite E1, San Diego CA 92121. Our telephone number is (858) 923-4422 and our website is www.aximbiotech.com.

Company Notes
Formerly=Axim International Inc until 7-2014
Pink Open Market Logo
Pink Current Information
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.